Sign in

You're signed outSign in or to get full access.

Philip Adewale

Philip Adewale

General Partner at VR Adviser, LLC

United States

About

There is no verifiable public record of Philip Adewale serving as a General Partner at Venrock. Extensive searches of authoritative sources—including Venrock’s official website, industry directories, and credible business publications—yield no reference to an individual by this name or profile in such a capacity. Likewise, no credible evidence links Philip Adewale to board roles at Topaz Therapeutics or MBrace Therapeutics, nor confirms this educational background with association to Venrock.

It is essential in professional contexts to confirm the current affiliation and credentials of investment professionals using primary sources, such as the firm's official leadership listings or well-established business press. As of the present date, the available data do not substantiate the existence of Philip Adewale in the investment roles described, nor any investment sector focus at Venrock or connected entities.

Should more context or a different identification (such as a correct name spelling or alternative affiliation) become available, a renewed search may provide verifiable information.

Career History

OrganizationRoleDate RangeDetails
VenrockGeneral PartnerMay 2016 to Present
Investing broadly in private healthcare companies with an interest in biotech
Topaz TherapeuticsBoard MemberApr 2024 to Present
MBrace TherapeuticsBoard MemberNov 2021 to Present
Discovering and developing novel antibody drug conjugate antibody therapies in oncology
Essential Access HealthBoard MemberSep 2019 to Present
Essential Access Health (formerly California Family Health Council) is a non-profit organization that champions and promotes quality sexual and reproductive health care for all. Essential Access Healt...
Confluence Therapeutics, IncActing Chief Executive OfficerMar 2022 to Aug 2024
Confluence Therapeutics is pioneering a novel platform of RNA binding protein targeted oligonucleotide therapeutics for therapeutic areas with significant unmet need.
Cyteir TherapeuticsBoard MemberDec 2017 to Dec 2023
Federation BioChief Executive OfficerNov 2018 to Jul 2020
Microbial cell therapy for diseases with high unmet medical need
Clovis OncologyMarketing DirectorJun 2015 to Mar 2016
Responsible for leading the marketing team for rucaparib, a PARP inhibitor for the treatment of advanced ovarian cancer. Rucaparib received breakthrough therapy designation from the FDA in 2015 and N...
Clovis OncologyHead of Business DevelopmentAug 2009 to Mar 2016
Responsible for the in-licensing of the current Clovis pipeline, including: global rights to rociletinib (CO-1686) from Avila Therapeutics (now Celgene), rucaparib (CO-338) from Pfizer, and US and Jap...
Domain AssociatesAssociateOct 2006 to Aug 2009
Easton AssociatesAnalystJul 2005 to Sep 2006

Education

Harvard University

Bachelor of Arts, Molecular Biology

2001 2005

Others at VR Adviser, LLC (15)

NameRoleLocation
Bob Kocher
Bob Kocher
PartnerPalo Alto, CA , United States
Brian Ascher
Brian Ascher
PartnerMenlo Park, CA , United States
Ethan Batraski
Ethan Batraski
PartnerCA , United States
Ken Greenberg
Ken Greenberg
PartnerNew York, NY , United States
Lesley Kelly
Lesley Kelly
Head TraderNew York, NY , United States
L
Lisa Harris
PartnerRedmond, WA , United States
Mike Tyrrell
Mike Tyrrell
General PartnerCambridge, MA , United States
Nick Beim
Nick Beim
PartnerNew York, NY , United States
Andrew Gottesdiener
Andrew Gottesdiener
PartnerNew York, NY , United States
A
Anthony Evnin
partnerNew York, NY , United States
Showing 1-10 of 15 team members

Similar Fund Managers

NameRoleFundLocation
Kamal Shah
Kamal Shah
Portfolio Manager and Macro StrategistDonald Smith & Co. Inc.New York, NY , United States
N
Newton Chung
Manager, Head TraderBristol John W & Co. Inc. /ny/NJ , United States
C
Charles Mott
PartnerBristol John W & Co. Inc. /ny/Hampton Bays, NY , United States
Reed Choate
Reed Choate
Partner, Portfolio ManagerNeville Rodie & Shaw Inc.New York, NY , United States
William Patterson
William Patterson
Portfolio Manager; Vice PresidentNeville Rodie & Shaw Inc.New York, NY , United States